I called Mike Gait to catch up with the work he has been doing for the last few years. When, towards the end of 2010, I first heard of his plans to develop a platform technology for delivery of a variety of cargoes using arrays of cell penetrating peptides (CPPs) I thought it was a… Read more »
Posts By: Sophie Rose
Cleveland, UK: Leading research peptide manufacturer Cambridge Research Biochemicals (CRB) announced today that it has signed a non-exclusive license with The Scripps Research Institute (TSRI) to add click chemistry services, namely the “click” labelling of peptides and proteins, to its existing service portfolio.
On Wednesday 17th September, leading British custom peptide and antibody provider Cambridge Research Biochemicals welcomed guests to ‘the Gardner Ratcliffe Building’ for its prestigious Official Opening Ceremony.
The role of transmembrane CTLA-4/ CD152 Receptor Transmembrane Cytotoxic T Lymphocyte Antigen 4 (Tm-CTLA-4) also known as CD152 plays a key role in downregulating the immune response and helping regulate immune homeostasis. Tm-CTLA-4 receptor is expressed on the surface of T cells, which lead the cellular immune attack on foreign as well as self antigens…. Read more »
Cambridge Research Biochemicals (“CRB”) and Key Organics Limited (“Key Organics”) today announced that they have entered into a worldwide exclusive supply & marketing agreement that makes CRB’s peptides available to Key Organics’ global life science customer base through its online BIONET catalogue.
Cambridge Research Biochemicals (CRB), offering expertise in the custom supply of research reagents, principally peptides and antibodies, has once again demonstrated customer satisfaction with the extension of an important contract in the medical research field.